Recent Finacing
Recent Raise
Freeno.me develops a cloud- and mobile-deployable platform analyzing cell-free circulating DNA to produce interpretable, actionable biomarkers for early cancer detection, treatment monitoring, and companion diagnostics.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor